Annonce

Log ud Log ind
Log ud Log ind
Finans

Morgan Stanley: Slut med de dyre aktier. Nu gælder det value

Hugo Gaarden

fredag 14. januar 2022 kl. 13:11

Morgan Stanley ser i denne tid en af de største kursændringer nogen sinde fra vækst- til valueaktier. Kursændringerne begyndte allerede i november. De dyreste aktier er drønet ned de sidste to måneder af 2021, meget mere end mange har lagt mærke til. De dyreste aktier er faldet med 30 pct. Kursfaldet er fortsat i år med 10 pct. På Nasdaq har 40 pct. af aktierne oplevet et fald på 50 pct. fra deres højdepunkter. Udviklingen skyldes primært stramningen af centralbankens pengepolitik (taper tantrum). Under så dramatiske pengepolitiske forandringer er de dyreste vækstaktier de mest sårbare. Derfor anbefaler Morgan Stanley at satse på valueaktier, og banken anbefaler investeringer i: Healthcare, Staples, REITs and Utilities and some financials. Vi er med andre ord tilbage til det, der giver brød på bordet. Den gode gamle Buffett, der altid har investeret i value og i aktier, som vedrører dagligdagens forbrug, ser ud til at få lidt oprejsning.

Uddrag fra Morgan Stanley:

WILL 2022 BE A 2013 ‘TAPER TANTRUM’ REDUX?

As the year gets underway, we are seeing an aggressive rotation from growth to value stocks, triggered by Fed tapering. Will 2022 follow the patterns of the ‘taper tantrum’ of 2013?

 

2022 is off to a blazing start with one of the most aggressive rotations from growth to value stocks we’ve ever seen. However, much of this rotation in the equity markets began back in November, with the Fed’s more aggressive pivot on monetary policy.

More specifically, the most expensive stocks in the market were down almost 30% in the last two months of 2021. Year to date, this cohort is down another 10%, leaving 40% of the Nasdaq stocks down more than 50% from their highs. Is the correction over in these expensive stocks yet?

What has changed since the turning of the calendar is that longer term interest rates have moved up significantly. In fact, the move in 10-year real rates is one of the sharpest on record and looks similar to the original taper tantrum in 2013.

However, as already mentioned, equity markets have been discounting this inevitable move in rates for months. Perhaps the real question is, why is the rates market suddenly waking up to the reality of higher inflation and the Fed’s response to it – something it has telegraphed for months?

We think it has to do with several tactical supports that are now being lifted. First, the Fed itself likely increased its liquidity provisions at year-end to support the typical constraints in the banking system. Meanwhile, many macro speculators and trading desks likely shut down their books in December, despite their fundamental view to be short bonds. This combination is now reversed and simply added fuel to a fire that had been burning for months under the surface.

Based on the move in 2013, it looks like real rates still have further to run, potentially much further. Our rates strategists believe real rates are headed back to negative 50 basis points, which is another 25 basis points higher. From our perspective, real rates are unreasonably negative given the very strong GDP growth. Therefore, the Fed is correct to be trying to get them higher. It’s also why tapering may not be tightening for the economy, even though it’s the epitome of tightening financial conditions for markets.

We have discussed this comparison to 2013 in prior research and made the following observations as it relates to equity markets.

First, the taper tantrum in 2013 was the first of its kind and something for which the markets had not been prepared. Therefore, the move in real rates was much more severe and swift than what we would expect this time around.

Second, valuations were much more attractive in 2013 based on both price/earnings multiples and the equity risk premiums, which adjust for absolute levels of rates, which are much lower today. Listeners may find it surprising to learn that the price/earnings multiple for the S&P 500 is actually higher today than when the Fed first announced its plan to taper asset purchases back in September. In other words, valuations have actually increased as the tapering has begun, at least for the broader S&P 500 index.

This is also similar to what happened in 2013 and makes sense. After all, Fed tightening is a good sign for growth and evidence that its policy has been successful. However, this time the starting point on valuations is much higher as already noted. More importantly, growth is decelerating, whereas in 2013 it was accelerating. This applies to both economic and earnings growth.

In this kind of an environment, the most expensive parts of the market remain the most vulnerable. This argues for value to outperform growth stocks. However, given the deceleration in growth, we favor the more defensive parts of value rather than the cyclicals like we did during the first quarter of 2021. This means Healthcare, Staples, REITs and Utilities. And some financials for a little offense to offset that portfolio.

Tilmeld dig vores gratis nyhedsbrev
ØU Top100 Finansvirksomhed

Få de vigtigste om bank, realkredit, forsikring, pension
Udkommer hver mandag.

Jeg giver samtykke til, at I sender mig mails med de seneste historier fra Økonomisk Ugebrev. Lejlighedsvis må I gerne sende mig gode tilbud og information om events. Samtidig accepterer jeg ØU’s Privatlivspolitik.

Du kan til enhver tid afmelde dig med et enkelt klik.

[postviewcount]

Jobannoncer

No data was found

Mere fra ØU Finans

Log ind

Har du ikke allerede en bruger? Opret dig her.

FÅ VORES STORE NYTÅRSUDGAVE AF FORMUE

Her er de 10 bedste aktier i 2022

Tilbuddet udløber om:
dage
timer
min.
sek.

Analyse af og prognoser for Fixed Income (statsrenter og realkreditrenter)

Direkte adgang til opdaterede analyser fra toneangivende finanshuse:

Goldman Sachs

Fidelity

Danske Bank

Morgan Stanley

ABN Amro

Jyske Bank

UBS

SEB

Natixis

Handelsbanken

Merril Lynch 

Direkte adgang til realkreditinstitutternes renteprognoser:

Nykredit

Realkredit Danmark

Nordea

Analyse og prognoser for kort rente, samt for centralbankernes politikker

Links:

RBC

Capital Economics

Yardeni – Central Bank Balance Sheet 

Investing.com: FED Watch Monitor Tool

Nordea

Scotiabank